Janne Backman
Helsingin yliopisto
H-index: 78
Europe-Finland
Top articles of Janne Backman
Genome‐Wide Association Study of Atorvastatin Pharmacokinetics: Associations With SLCO1B1, UGT1A3, and LPP
Clinical Pharmacology & Therapeutics
2024/3/17
Non‐targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function
Clinical and Translational Science
2024/3
The effect of hydroxychloroquine on cholesterol synthesis depends on the profile of cholesterol metabolism. A controlled clinical study
Atherosclerosis Plus
2024/3/1
Influence of Intravenous S-Ketamine on the Pharmacokinetics of Oral Morphine in Healthy Volunteers
Anesthesia & Analgesia
2024/3/1
Screening of 16 major drug glucuronides for time-dependent inhibition of nine drug-metabolizing CYP enzymes–detailed studies on CYP3A inhibitors
European Journal of Pharmaceutical Sciences
2024/2/27
Posaconazole‐ibrutinib interaction cannot be avoided by staggered dosing: How to optimize ibrutinib dose during posaconazole treatment
British Journal of Clinical Pharmacology
2024/2
Drug‐related deaths in a university hospital: Comparison to previous decades
Basic & Clinical Pharmacology & Toxicology
2024/1
Ticagrelor increases exposure to the breast cancer resistance protein substrate rosuvastatin
Clinical Pharmacology & Therapeutics
2024/1
The effect of hydroxychloroquine on cholesterol metabolism in statin treated patients after myocardial infarction
Atherosclerosis Plus
2023/9
Introduction of an electrochemical point‐of‐care assay for quantitative determination of paracetamol in finger‐prick capillary whole blood samples
British Journal of Clinical Pharmacology
2023/9
P562: CAPILLARY BLOOD SAMPLING ALLOWS FEASIBLE METHOD FOR VENETOCLAX CONCENTRATION MEASUREMENT IN AN ACADEMIC MULTICENTER CLINICAL TRIAL CONTEXT
HemaSphere
2023/8/1
Elucidating the drug-drug interaction risks caused by time-dependent inhibition of CYP3A by hydroxychloroquine metabolites
2023/7/2
Janne Backman
H-Index: 36
Mikko Niemi
H-Index: 5
Elucidating the drug-drug interaction potential of hydroxychloroquine metabolites due to direct and time-dependent inhibition of CYP3A
2023/6/14
Mikko Niemi
H-Index: 5
Janne Backman
H-Index: 36
Carvedilol is a time-dependent inhibitor of CYP3A
2023/6/14
Mikko Niemi
H-Index: 5
Janne Backman
H-Index: 36
Elucidating the drug–drug interaction potential of hydroxychloroquine metabolites due to direct and time-dependent inhibition of CYP3A In: ABSTRACTS FROM SECOND NORDIC …
Basic & Clinical Pharmacology & Toxicology
2023/6/1
Mikko Niemi
H-Index: 5
Janne Backman
H-Index: 36
Hydroxychloroquine is metabolized by cytochrome P450 2D6, 3A4, and 2C8, and inhibits cytochrome P450 2D6, while its metabolites also inhibit cytochrome P450 3A in vitro
Drug Metabolism and Disposition
2023/3/1
Psyykenlääkkeet ja farmakogeneettiset laboratoriotutkimukset-miten hyödynnät?
Suomen lääkärilehti
2023
Janne Backman
H-Index: 36
Mikko Niemi
H-Index: 5
Lääkkeiden aiheuttamat maksavauriot
2023
Janne Backman
H-Index: 36
A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics
British Journal of Clinical Pharmacology
2023/1
Hydroxychloroquine is metabolized by CYP2D6, CYP3A4, and CYP2C8, and inhibits CYP2D6, while its metabolites also inhibit CYP3A in vitro
Drug Metabolism and Disposition
2023/1/1
